APO Research

APO RESEARCH · REPORT

Substance P

Selected research

Market Structure

Global Substance P Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Substance P market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Substance P is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Substance P is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Substance P is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Substance P is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Substance P include Tocris Bioscience, R and D Systems, Peptide Institute, Genscript and BioCrick, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Substance P market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Substance P and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Substance P sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Substance P market size, projected growth trends, production technologies, key applications, and end-use industries.

Substance P Segment by Company

Tocris Bioscience

R and D Systems

Peptide Institute

Genscript

BioCrick

Substance P Segment by Type

Rat

Bovine

Human

Mouse

Substance P Segment by Application

Scientific Research

Medical

Others

Substance P Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Substance P market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Substance P and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Substance P.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Substance P market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Substance P manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Substance P in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Substance P in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Substance P Industry Trends Table 2. Substance P Industry Drivers Table 3. Substance P Industry Opportunities and Challenges Table 4. Substance P Industry Restraints Table 5. Global Substance P Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Substance P Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Substance P Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Substance P Sales Market Share by Manufacturers Table 9. Global Substance P Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Substance P Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Substance P Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Substance P Manufacturers, Product Type & Application Table 13. Global Substance P Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Substance P by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Rat Table 17. Major Manufacturers of Bovine Table 18. Major Manufacturers of Human Table 19. Major Manufacturers of Mouse Table 20. Global Substance P Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Substance P Sales by Type (2021-2026) & (K Units) Table 22. Global Substance P Sales by Type (2027-2032) & (K Units) Table 23. Global Substance P Sales Market Share by Type (2021-2026) Table 24. Global Substance P Sales Market Share by Type (2027-2032) Table 25. Global Substance P Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Substance P Revenue by Type (2021-2026) & (K Units) Table 27. Global Substance P Revenue by Type (2027-2032) & (K Units) Table 28. Global Substance P Revenue Market Share by Type (2021-2026) Table 29. Global Substance P Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Scientific Research Table 31. Major Manufacturers of Medical Table 32. Major Manufacturers of Others Table 33. Global Substance P Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Substance P Sales by Application (2021-2026) & (K Units) Table 35. Global Substance P Sales by Application (2027-2032) & (K Units) Table 36. Global Substance P Sales Market Share by Application (2021-2026) Table 37. Global Substance P Sales Market Share by Application (2027-2032) Table 38. Global Substance P Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Substance P Revenue by Application (2021-2026) & (K Units) Table 40. Global Substance P Revenue by Application (2027-2032) & (K Units) Table 41. Global Substance P Revenue Market Share by Application (2021-2026) Table 42. Global Substance P Revenue Market Share by Application (2027-2032) Table 43. Global Substance P Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Substance P Sales by Region (2021-2026) & (K Units) Table 45. Global Substance P Sales Market Share by Region (2021-2026) Table 46. Global Substance P Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Substance P Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Substance P Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Substance P Sales by Country (2021-2026) & (K Units) Table 50. North America Substance P Sales by Country (2027-2032) & (K Units) Table 51. Europe Substance P Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Substance P Sales by Country (2021-2026) & (K Units) Table 53. Europe Substance P Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Substance P Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Substance P Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Substance P Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Substance P Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Substance P Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Substance P Sales by Country (2027-2032) & (K Units) Table 60. Global Substance P Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Substance P Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Substance P Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Substance P Revenue Market Share by Region (2021-2026) Table 64. Global Substance P Revenue Market Share by Region (2027-2032) Table 65. Tocris Bioscience Company Information Table 66. Tocris Bioscience Business Overview Table 67. Tocris Bioscience Substance P Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Tocris Bioscience Substance P Product Portfolio Table 69. Tocris Bioscience Recent Development Table 70. R and D Systems Company Information Table 71. R and D Systems Business Overview Table 72. R and D Systems Substance P Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. R and D Systems Substance P Product Portfolio Table 74. R and D Systems Recent Development Table 75. Peptide Institute Company Information Table 76. Peptide Institute Business Overview Table 77. Peptide Institute Substance P Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Peptide Institute Substance P Product Portfolio Table 79. Peptide Institute Recent Development Table 80. Genscript Company Information Table 81. Genscript Business Overview Table 82. Genscript Substance P Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Genscript Substance P Product Portfolio Table 84. Genscript Recent Development Table 85. BioCrick Company Information Table 86. BioCrick Business Overview Table 87. BioCrick Substance P Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. BioCrick Substance P Product Portfolio Table 89. BioCrick Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Substance P Distributors List Table 93. Substance P Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Substance P Product Image Figure 2. Global Substance P Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Substance P Market Size (2021-2032) & (US$ Million) Figure 4. Global Substance P Sales (2021-2032) & (K Units) Figure 5. Global Substance P Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Substance P Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Rat Image Figure 9. Bovine Image Figure 10. Human Image Figure 11. Mouse Image Figure 12. Global Substance P Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Substance P Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Substance P Sales Market Share by Type (2021-2032) Figure 15. Global Substance P Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Substance P Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Substance P Revenue Market Share by Type (2021-2032) Figure 18. Scientific Research Image Figure 19. Medical Image Figure 20. Others Image Figure 21. Global Substance P Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Substance P Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Substance P Sales Market Share by Application (2021-2032) Figure 24. Global Substance P Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Substance P Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Substance P Revenue Market Share by Application (2021-2032) Figure 27. North America Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Substance P Sales Market Share by Country (2021-2032) Figure 29. U.S. Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Substance P Sales Market Share by Country (2021-2032) Figure 34. Germany Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Substance P Sales Market Share by Country (2021-2032) Figure 41. China Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Substance P Sales Market Share by Country (2021-2032) Figure 49. Brazil Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Substance P Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Substance P Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Substance P Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Substance P Revenue (2021-2032) & (US$ Million) Figure 60. North America Substance P Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Substance P Revenue (2021-2032) & (US$ Million) Figure 62. Europe Substance P Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Substance P Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Substance P Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Substance P Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Substance P Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Substance P Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Substance P Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Rat
  • Bovine
  • Human
  • Mouse
Applications
  • Scientific Research
  • Medical
  • Others
Companies covered
  • Tocris Bioscience
  • R and D Systems
  • Peptide Institute
  • Genscript
  • BioCrick

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Substance P Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Substance P Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Substance P Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Substance P Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Substance P Market Dynamics
  1. 2.1 Substance P Industry Trends
  2. 2.2 Substance P Industry Drivers
  3. 2.3 Substance P Industry Opportunities and Challenges
  4. 2.4 Substance P Industry Restraints
3 Substance P Market by Manufacturers
  1. 3.1 Global Substance P Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Substance P Sales by Manufacturers (2021-2026)
  3. 3.3 Global Substance P Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Substance P Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Substance P Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Substance P Manufacturers, Product Type & Application
  7. 3.7 Global Substance P Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Substance P Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Substance P Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Substance P Tier 1, Tier 2, and Tier 3
4 Substance P Market by Type
  1. 4.1 Substance P Type Introduction
  2. 4.1.1 Rat
  3. 4.1.2 Bovine
  4. 4.1.3 Human
  5. 4.1.4 Mouse
  6. 4.2 Global Substance P Sales by Type
  7. 4.2.1 Global Substance P Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Substance P Sales by Type (2021-2032)
  9. 4.2.3 Global Substance P Sales Market Share by Type (2021-2032)
  10. 4.3 Global Substance P Revenue by Type
  11. 4.3.1 Global Substance P Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Substance P Revenue by Type (2021-2032)
  13. 4.3.3 Global Substance P Revenue Market Share by Type (2021-2032)
5 Substance P Market by Application
  1. 5.1 Substance P Application Introduction
  2. 5.1.1 Scientific Research
  3. 5.1.2 Medical
  4. 5.1.3 Others
  5. 5.2 Global Substance P Sales by Application
  6. 5.2.1 Global Substance P Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Substance P Sales by Application (2021-2032)
  8. 5.2.3 Global Substance P Sales Market Share by Application (2021-2032)
  9. 5.3 Global Substance P Revenue by Application
  10. 5.3.1 Global Substance P Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Substance P Revenue by Application (2021-2032)
  12. 5.3.3 Global Substance P Revenue Market Share by Application (2021-2032)
6 Global Substance P Sales by Region
  1. 6.1 Global Substance P Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Substance P Sales by Region (2021-2032)
  3. 6.2.1 Global Substance P Sales by Region (2021-2026)
  4. 6.2.2 Global Substance P Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Substance P Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Substance P Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Substance P Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Substance P Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Substance P Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Substance P Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Substance P Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Substance P Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Substance P Revenue by Region
  1. 7.1 Global Substance P Revenue by Region
  2. 7.1.1 Global Substance P Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Substance P Revenue by Region (2021-2026)
  4. 7.1.3 Global Substance P Revenue by Region (2027-2032)
  5. 7.1.4 Global Substance P Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Substance P Revenue (2021-2032)
  8. 7.2.2 North America Substance P Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Substance P Revenue (2021-2032)
  11. 7.3.2 Europe Substance P Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Substance P Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Substance P Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Substance P Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Substance P Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Tocris Bioscience
  2. 8.1.1 Tocris Bioscience Company Information
  3. 8.1.2 Tocris Bioscience Business Overview
  4. 8.1.3 Tocris Bioscience Substance P Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Tocris Bioscience Substance P Product Portfolio
  6. 8.1.5 Tocris Bioscience Recent Developments
  7. 8.2 R and D Systems
  8. 8.2.1 R and D Systems Company Information
  9. 8.2.2 R and D Systems Business Overview
  10. 8.2.3 R and D Systems Substance P Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 R and D Systems Substance P Product Portfolio
  12. 8.2.5 R and D Systems Recent Developments
  13. 8.3 Peptide Institute
  14. 8.3.1 Peptide Institute Company Information
  15. 8.3.2 Peptide Institute Business Overview
  16. 8.3.3 Peptide Institute Substance P Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Peptide Institute Substance P Product Portfolio
  18. 8.3.5 Peptide Institute Recent Developments
  19. 8.4 Genscript
  20. 8.4.1 Genscript Company Information
  21. 8.4.2 Genscript Business Overview
  22. 8.4.3 Genscript Substance P Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Genscript Substance P Product Portfolio
  24. 8.4.5 Genscript Recent Developments
  25. 8.5 BioCrick
  26. 8.5.1 BioCrick Company Information
  27. 8.5.2 BioCrick Business Overview
  28. 8.5.3 BioCrick Substance P Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BioCrick Substance P Product Portfolio
  30. 8.5.5 BioCrick Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Substance P Value Chain Analysis
  2. 9.1.1 Substance P Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Substance P Production Mode & Process
  6. 9.2 Substance P Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Substance P Distributors
  9. 9.2.3 Substance P Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research